FOMDWebPartPage

2016 Publications

1.      Reeve J, Chang J, Salazar IDR, Lopez MM, and Halloran PF. Using molecular phenotyping to guide improvements in the histologic diagnosis of T cell-mediated rejection. Am J Transplant 2016;(4):1183-92.

2.      Halloran, PF, Lopez MM, and  Pereira AB. Identifying sub-phenotypes of antibody-mediated rejection in kidney transplants. Am J Transplant 2016;(3):908-20.​​

3.      Venner JM, Famulski KS, Reeve J, Chang J and Halloran PF. Relationships among injury, fibrosis, and time in human kidney transplants. Journal of Clinical Investigation Insight 2016;1(1):e85323.

4.      Loupy A, Duong Van Huyen JP, Hildalgo LG, Reeve J, Racape M, Venner JM, Famulski KS, Bories MC, Beauscart T, Guillemain R, Francois A, Pattier S, Toquet C, Gay A, Rouvier P, Varnous S, Leprince P, Empana JP, Lefaucheur C, Bruneval P, Jouven X and Halloran PF. The Molecular Landscape of Antibody-Mediated Rejection in Heart Transplant Patients: Insights for Mechanisms, Activity and Stage. Circulation 2016; in press.​​

5.      Halloran PF, Famulski KS and Reeve J. Molecular assessment of disease states in kidney transplant biopsies. Nature Reviews Nephrology 2016; doi:10.1038/nrneph.2016.85. Published online 27 June 2016;1-16.

8.      Parkes MD, Halloran PF and Hidalgo LG. Evidence for CD16a-mediated NK cell stimulation in antibody-mediated kidney transplant rejection. Transplantation 2016; in press.
http://journals.lww.com/transplantjournal/Abstract/onlinefirst/Evidence_for_CD16a_mediated_NK_Cell_Stimulation_in.97114.aspx

9.    Einecke G, Reeve J and Halloran PF. Hyalinosis lesions in renal transplant biopsies: interpretation depends on TxBx interval. Am J Transplant 2016; in press.
http://onlinelibrary.wiley.com/doi/10.1111/ajt.14136/full​